Skip to main content
SpringerLink
Log in

Hepatitis Viruses

  • Chapter
Viral Diseases in Pregnancy

Part of the book series: Clinical Perspectives in Obstetrics and Gynecology ((CPOG))

  • 117 Accesses

Abstract

Acute hepatitis may be caused by a number of infectious and noninfectious etiologies. Among the viruses, a continually expanding list of organisms are being identified. This is due, in part, to rapidly developing advances in molecular biology where now minute quantities of viral load can be amplified, sequenced, and immunologically identified. Many of these agents, when retrospectively analyzed, were responsible for hepatitis outbreaks in years past. Clinically, most of these infections cannot be distinguished from one another during their acute presentation. Variations do exist in incubation periods, modes of transmission, fulminance, and effects during pregnancy. This chapter deals with hepatitis A, B, C, D, and E. Other agents such as cytomegalovirus and Epstein-Barr virus are also associated with hepatic involvement and are discussed in other chapters.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Blumer G. Infectious jaundice in the United States. JAMA. 1923; 81: 353–358.

    Google Scholar 

  2. Havens WP Jr. Properties of the etiologic agent of infectious hepatitis.Proc Soc Exp Biol Med. 1945; 58: 203–204.

    Google Scholar 

  3. Feinstone SM, Kapikian AZ, Purcell RH. Hepatitis A: Detection by immune electron microscopy of a viruslike antigen associated with acute illness. Science. 1973;182:1026–1028.

    PubMed  CAS  Google Scholar 

  4. Dienstag JL, Feinstone SM, Kapikian AZ, et al. Faecal shedding of hepatitis A antigen. Lancet. 1975; 1: 765–767.

    PubMed  CAS  Google Scholar 

  5. Siegl G, Frosner GG. Characterization and classification of virus particles asssociated with hepatitis A. I. Size, density, and sedimentation. J Virol 1978; 26: 40–47.

    PubMed  CAS  Google Scholar 

  6. Schulman AN, Dienstag JL, Jackson DR, et al. Hepatitis A antigen particles in liver, bile, and stool of chimpanzees. J Infect Dis. 1976; 134: 80–84.

    PubMed  CAS  Google Scholar 

  7. Provost PJ, Hilleman MR. Propagation of human hepatitis A virus in cell culture in vitro. Proc Soc Exp Biol Med. 1979;160:213–221.

    PubMed  CAS  Google Scholar 

  8. Mathiesen LR, Drucker J, Lorenz D, et al. Localization of hepatitis A antigen in marmoset organs during acute infection with hepatitis A virus. J Infect Dis. 1978;138:369– 377.

    PubMed  Google Scholar 

  9. Provost PJ, Ittensohn OL, Villarejos VM, et al. Etiologic relationship of marmoset-propagated CR326 hepatitis A virus to hepatitis in man. Proc Soc Exp Biol Med. 1973;142:1257–1267.

    PubMed  CAS  Google Scholar 

  10. McCaustland KA, Bond WW, Bradley DW, et al. Survival of hepatitis A virus in feces after drying and storage for one month. J Clin Microbiol. 1982; 16: 957–958.

    PubMed  CAS  Google Scholar 

  11. Siegl G. Structure and biology of hepatitis A virus. In: Szmuness W, Alter HJ, Maynard JE, eds. Viral Hepatitis. Philadelphia: Franklin Institute Press; 1982: 13–20.

    Google Scholar 

  12. Provost PJ, Wolanski BS, Miller WJ, et al. Physical, chemical and morphologic dimensions of human hepatitis strain CR326. Proc Soc Exp Biol Med. 1975; 148: 532–539.

    PubMed  CAS  Google Scholar 

  13. Krugman S, Giles JP, Hammond J. Hepatitis virus: Effect of heat on the infectivity and antigenicity of the MS-1 and MS-2 strain. J Infect Dis. 1970; 122: 423–436.

    Google Scholar 

  14. Ping L-H, Lemon SM. Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies. J Virol. 1992; 66: 2208–2216.

    PubMed  CAS  Google Scholar 

  15. Robertson BH, Jansen RW, Khanna B, et al. Genetic relatedness of hepatitis A virus strains recovered from different geograpic regions. J Gen Virol. 1992; 73: 1365–1377.

    PubMed  CAS  Google Scholar 

  16. Arankalle VA, Ticehurst J, Sreenivasan MA, et al. Etiologic association of a viruslike particle with enterically-transmitted non-A, non-B hepatitis. Lancet. 1988; 1: 550–554.

    PubMed  CAS  Google Scholar 

  17. Hoofnagle JH, Ponzetto A, Mathiesen LR, et al. Serologic diagnosis of acute viral hepatits. Dig Dis Sci. 1985; 30: 1022–1027.

    PubMed  CAS  Google Scholar 

  18. Gust ID. Comparison of the epidemiology of hepatitis A and B. In: Szmuness W, Alter HJ, Maynard JE, eds. Viral Hepatitis. Philadelphia: Franklin Institute Press; 1982: 129–143.

    Google Scholar 

  19. Mosley JW . Water-borne infectious hepatitis. N Engl J Med. 1959;261:703-708,748–753.

    PubMed  CAS  Google Scholar 

  20. Mosley JW, Schrack WD Jr, Densham TW, et al. Infectious hepatitis in Clearfield County, Pennsylvania. I. A probable water-borne epidemic. Am J Med. 1959; 26: 555–558.

    PubMed  CAS  Google Scholar 

  21. Morse LJ, Bryan JW, Hurley JP, et al. The Holy Cross College football team hepatitis outbreak. JAMA. 1972; 219: 706–708.

    PubMed  CAS  Google Scholar 

  22. Ruddy SJ, Johnson RF, Mosley JW, et al. An epidemic of clam-associated hepatitis. JAMA. 1969; 208: 649–655.

    PubMed  CAS  Google Scholar 

  23. Mackowiak PA, Caraway CT, Portnoy BL. Oyster-associated hepatitis: Lessons from the Louisiana experience. Am J Epidemiol. 1976; 103: 181–191.

    PubMed  CAS  Google Scholar 

  24. Levy BS, Fontaine RE, Smith CA, et al. A large food-borne outbreak of hepatitis A: Possible transmission via oropharyngeal secretions. JAMA. 1975; 234: 289–294.

    PubMed  CAS  Google Scholar 

  25. Meyers JD, Romm FJ, Tihen WS, et al. Food-borne hepatitis A in a general hospital: Epidemiologic study of an outbreak attrib-uted to sandwiches. JAMA. 1975;231:1049–1053.

    PubMed  CAS  Google Scholar 

  26. Purcell RH, Feinstone, SM, Ticehurst JR, et al. Hepatitis A virus. In: Vyas GN, Dienstag JL, Hoofnagle JH, eds. Viral Hepatitis and Liver Disease. Orlando, FL: Grune & Stratton; 1984: 9–22.

    Google Scholar 

  27. Margolis HS, Naiman OV. Identification of hepatitis A viral capsid proteins in immune complexes isolated during hepatitis A infection. J Med Virol. 1987; 22: 20A.

    Google Scholar 

  28. Kurane I, Binn LN, Bancroft WH, et al. Human lymphocyte responses to hepatitis A virus-infected cells: Interferon production and lysis of infected cells. J Immunol. 1985; 135: 2140–2144.

    PubMed  CAS  Google Scholar 

  29. Zachoval R, Abb J, Zachoval V, et al. Circulating interferon in patients with acute hepatitis A. J Infect Dis. 1986; 153: 1174–1175.

    PubMed  CAS  Google Scholar 

  30. Lemon SM. Type A viral hepatitis. New developments in an old disease. N Engl J Med. 1985; 313: 1059–1067.

    PubMed  CAS  Google Scholar 

  31. Krugman S, Ward R, Giles JP. The natural history of infectious hepatitis. Am J Med. 1962; 32: 717–728.

    PubMed  CAS  Google Scholar 

  32. Routenberg JA, Dienstag JL, Harrison WO, et al. A food borne outbreak of hepatitis A: Clinical and laboratory features of acute and protracted illness. Am J Med Sci. 1979; 278: 123–137.

    PubMed  CAS  Google Scholar 

  33. Inman RD, Hodge M, Johnston MEA, et al. Arthritis, vasculitis, and cryoglobulinemia associated with relapsing hepatitis A virus infection. Ann Intern Med. 1986; 105: 700–703.

    PubMed  CAS  Google Scholar 

  34. Hallam A, Kerlin P. Viral hepatitis A to E. An update. Aust Fam Phys. 1991; 20: 760–770.

    CAS  Google Scholar 

  35. Hirvioja M-L, Tuimala R, Vuori J. The treatment of intrahepatic cholestasis of pregnancy by dexamethasone. Br J Obstet Gynecol. 1992; 99: 109–111.

    CAS  Google Scholar 

  36. Gust ID . The epidemiology of viral hepatitis. In: Vyas GN, Dienstag JL, Hoofnagle JH, eds. Viral Hepatitis and Liver Disease. Orlando, FL; Grune & Stratton; 1984:415–418.

    Google Scholar 

  37. Borhanmanesh F, Haghig P, Hekmat K, et al. Viral hepatitis during pregnancy: Severity and effect on gestation. Gastroenterology. 1973; 64: 304–312.

    PubMed  CAS  Google Scholar 

  38. Khuroo MS, Teli MR, Skidmore S, et al. Incidence and severity of viral hepatitis in pregnancy. Am J Med. 1981; 70: 252–255.

    PubMed  CAS  Google Scholar 

  39. Shwer M, Moosa A. The effects of hepatitis A and B in pregnancy on mother and fetus. S Afr Med J. 1978; 54: 1092–1095.

    PubMed  CAS  Google Scholar 

  40. Tong MJ, Thursby M, Rakela J, et al. Studies on the maternal-infant transmission of the viruses which cause acute hepatitis. Gastroenterology. 1981; 80: 999–1004.

    PubMed  CAS  Google Scholar 

  41. Rosenblum LS, Villarino ME, Nainan OV, et al. Hepatitis A outbreak in a neonatal intensive care unit: Risk factors for transmission and evidence of prolonged viral excretion among preterm infants. J Infect Dis. 1991; 164: 476–482.

    PubMed  CAS  Google Scholar 

  42. Zhang RL, Zeng JS, Zhang HZ. Survey of 34 pregnant women with hepatitis A and their neonates. Chin Med J (Engl). 1990;103:552–555.

    CAS  Google Scholar 

  43. Zhuang YL. Acute hepatitis A in pregnancy: A report of 43 cases. Chung-Hua Fu Chan Ko Tsa Chih. 1989; 24: 136–138.

    PubMed  CAS  Google Scholar 

  44. Centers for Disease Control. Protection against viral hepatitis. Recommendations of the Immunization Practices Advisory Com-mittee (ACIP). Morb Mortal Wkly Rep. 1990; 39 (RR-2): 1–26.

    Google Scholar 

  45. Duermeyer W, Wielaard F, van der Veen J. A new principle for the detection of specific IgM antibodies applied in an ELISA for hepatitis A.J Med Virol 1979; 4: 25–32.

    CAS  Google Scholar 

  46. Kao HW, Ashcavai M, Redeker AG. The persistence of hepatitis A IgM antibody after acute clinical hepatitis A virus. Hepatology. 1984; 4: 933–936.

    PubMed  CAS  Google Scholar 

  47. Lemon SM. Inactivated hepatitis A virus vaccines. Hepatology. 1992; 15: 1194–1197.

    PubMed  CAS  Google Scholar 

  48. Stapleton JT, Jansen RW, Lemon SM. Neutralizing antibody to hepatitis A virus in immune serum globulin and in the sera of human recipients of immune serum globulin. Gastroenterology. 1985; 89: 637–642.

    PubMed  CAS  Google Scholar 

  49. Fujiyama S, Iino S, Odoh K, et al. Time course of hepatitis A virus antibody titer after active and passive immunization. Hepatology. 1992; 15: 983–988.

    PubMed  CAS  Google Scholar 

  50. Blumberg BS, Alter HJ, Visnich S. A “new” antigen in leukemia sera. JAMA. 1965; 191: 541–546.

    PubMed  CAS  Google Scholar 

  51. Alter HJ, Blumberg BS. Further studies on a new human isoprecipitin system (Australia antigen). Blood. 1966; 27: 297–309.

    PubMed  CAS  Google Scholar 

  52. Bayer ME, Blumberg BS, Werner B. Particles associated with Australia antigen in the sera of patients with leukemia, Down’s syndrome, and hepatitis. Nature. 1968;218:1057–1059.

    PubMed  CAS  Google Scholar 

  53. Dane DS, Cameron CH, Briggs M. Virus-like particles in serum of patients with Australia angtigen-associated hepatitis. Lancet. 1970; 2: 695–698.

    Google Scholar 

  54. Magnius LO. Characterization of a new antigen-antibody system associated with hepatitis B. Clin Exp Immunol. 1975; 20: 209–216.

    PubMed  CAS  Google Scholar 

  55. Alter HJ, Seeff LB, Kaplan PM, et al. Type B hepatitis: The infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. N Engl J Med. 1976; 296: 909–913.

    Google Scholar 

  56. Ohori H, Onodera S, Ishida N. Demonstration of hepatitis B e antigen (HBeAg) with intact Dane particles. J Gen Virol. 1979; 43: 423–427.

    PubMed  CAS  Google Scholar 

  57. Magnius LO, Lindholm A, Lundin P, et al. A new antigen-antibody system. Clinical significance in long-term carriers of hepatitis B surface antigen. JAMA. 1975; 231: 356–369.

    PubMed  CAS  Google Scholar 

  58. Trepo C, Mangius L, Schaefer RA, et al. Detection and clinical significance of e antigen and antie antibody in hepatits B surface antigen carriers. Gastroenterology. 1975; 69: 872.

    Google Scholar 

  59. Hoofnagle, JH, Seeff LB, Bales ZB, et al. Serologic responses in hepatitis B. In: Vyas GN, Cohen SN, Schmid T, eds. Viral Hepatitis: A Contemporary Assessment of Etiology, Epidmiology, Pathogenesis, and Prevention. Philadelphia: Franklin Institute Press, 1978: 219–242.

    Google Scholar 

  60. Tabor E, Gerety RJ. Possible role of immune response to hepatitis B core antigen in protection against hepatitis B infection. Lancet. 1984; 1: 172.

    PubMed  CAS  Google Scholar 

  61. Murray K, Bruce SA, Hinnen A, et al. Hepatitis B virus antigens made in microbial cells immunise against viral infection. EMBO J. 1984; 3: 645–650.

    PubMed  CAS  Google Scholar 

  62. Prince AM. Mechanism of protection against hepatitis B infection by immunization with hepatitis B virus cores. Lancet. 1984; 1: 512.

    PubMed  CAS  Google Scholar 

  63. Purcell RH, Gerin JL. Hepatitis B subunit vaccine: A preliminary report of safety and efficacy tests in chimpanzees. Am J Med Sci. 1975; 270: 395–399.

    PubMed  CAS  Google Scholar 

  64. Hoofnagle JH. Toward universal vaccination against hepatitis B virus. N Engl J Med. 1989; 321: 1333–1334.

    PubMed  CAS  Google Scholar 

  65. Beasley RP, Hwang LY. Epidemiology of hepatocellular carcinoma. In: Vyas GN, Dienstag JL, Hoofnagle JH, eds. Viral Hepatitis and Liver Disease. Proceedings of the 1984 International Symposium on Viral Hepatitis. Orlando, FL: Grune and Stratton; 1984: 209–224.

    Google Scholar 

  66. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. Lancet. 1981; 2: 1129–1133.

    PubMed  CAS  Google Scholar 

  67. World Health Organization. Prevention of liver cancer: Report of a WHO meeting. WHO Tech Rep Ser. 1988; 691: 8–9.

    Google Scholar 

  68. Stevens CE, Beasley RP, Tsui J, Lee W-C. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med. 1975; 292: 771–774.

    PubMed  CAS  Google Scholar 

  69. Stevens CE, Toy PT, Tong MJ, et al. Perinatal hepatitis B virus transmission in the United States: Prevention by passive-active immunization. JAMA. 1985; 253: 1740–1745.

    PubMed  CAS  Google Scholar 

  70. Centers for Disease Control. Inactivated hepatitis B virus vaccine. MMWR Morb Mortal Wkly Rep. 1982; 31: 318.

    Google Scholar 

  71. Barker LF, Murray R. Relationship of virus dose to incubation time of clinical hepatitis and time of appearance of hepatitis-associated antigen. Am J Med Sci. 1972; 263: 27–33.

    PubMed  CAS  Google Scholar 

  72. Bancroft WH, Snitbhan R, Scott RM, et al. Transmission of hepatitis B virus to gibbons by exposure to human saliva containing hepatitis B surface antigen. J Infect Dis. 1977; 135: 79–85.

    PubMed  CAS  Google Scholar 

  73. Alter JH, Purcell RH, Gerin JL, et al. Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen-positive saliva and semen. Infect Immun. 1977; 16: 928–933.

    PubMed  CAS  Google Scholar 

  74. Centers of Disease Control. Hepatitis transmitted by a human bite. Morb Mortal Wkly Rep. 1974; 23: 24.

    Google Scholar 

  75. Neefe JR, Gellis SS, Stokes J. Homologous serum hepatitis and infectious (epidemic) hepatitis: Studies in volunteers bearing on immunological and other characteristics of the etiological agents. Am J Med. 1946; 1: 3–22.

    PubMed  CAS  Google Scholar 

  76. Centers for Disease Control. Update on hepatitis B prevention. Morb Mortal Wkly Rep. 1989; 36: 353–360.

    Google Scholar 

  77. Gocke DJ. Type B hepatitis-Good news and bad news. NEngl JMed. 1974; 291: 1409–1114.

    CAS  Google Scholar 

  78. Pattison CP, Boyer KM, Maynard JE, Kelly PC. Epidemie hepatitis in a clinical laboratory: Possible association with computer card handling. JAMA. 1974; 230: 854–857.

    PubMed  CAS  Google Scholar 

  79. Mirick GS, Shank RE. An epidemic of serum hepatitis studied under controlled conditions. Trans Am Climatol Assoc. 1959; 71: 176.

    CAS  Google Scholar 

  80. Hersh T, Melnick JL, Goyal RK, Hollinger FB. Nonparenteral transmission of viral hepatitis type B (Australia antigen-associated serum hepatitis). N Engl J Med. 1971; 285: 1363–1364.

    PubMed  CAS  Google Scholar 

  81. Szmuness W, Harley EJ, Prince AM. Intrafamilial spread of asymptomatic hepatitis B. Am J Med Sci. 1975; 270: 293–304.

    PubMed  CAS  Google Scholar 

  82. Vechon TM,Wright RA,Merrill DA.Hepatitis A and B in the family unit: nonparenteral transmission by asymptomatic children.JAMA1976;235:2829–2831.

    Google Scholar 

  83. Bernier RH, Sampliner R, Gerety R, Tabor E, Hamilton F, Nathanson N. Hepatitis B infection in households of chronic carriers of hepatitis B surface antigen: Factors associated with prevalence of infection. Am J Epidemiol. 1982; 116: 199–211.

    PubMed  CAS  Google Scholar 

  84. Beasley RP, Hwang LY, Lin CC, et al. Incidence of hepatitis B virus infections in pre-school children in Taiwan. J Infect Dis. 1982; 146: 198–204.

    PubMed  CAS  Google Scholar 

  85. Maupas P, Chiron JP, Barin F, et al. Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children: Controlled trial in an endemic area (Senegal). Lancet. 1981; 1: 289–292.

    PubMed  CAS  Google Scholar 

  86. Gocke JD. Immune complex phenomena associated with hepatitis. In: Vyas GN, Cohen SN, Schmidt R, eds. Viral Hepatitis: A Contemporary Assessment of Etiology, Epidemiology, Pathogenesis, and Prevention. Philadelphia: Franklin Institute Press; 1978: 277.

    Google Scholar 

  87. Wands JR, Mann EA, Alpert E, Isselbacher KJ. The pathogenesis of arthritis associated with acute hepatitis B surface antigen positive hepatitis: Complement activation and characterization of circulating immune complexes. J Clin Invest. 1975; 55: 930–936.

    PubMed  CAS  Google Scholar 

  88. Shulman RN. Hepatitis-associated antigen. Am J Med. 1971; 49: 669–692.

    Google Scholar 

  89. Krugman S, Overby LR, Mushahwar IK, Ling CM, Frosher GG, Deinhardt F. Viral hepatitis, type B: Studies on natural history and prevention reexamined. N Engl J Med. 1979; 300: 101–106.

    PubMed  CAS  Google Scholar 

  90. Lander JJ, Giles JP, Purcell RH. Frequency of antibody to hepatitis-associated antigen as measured by a new radioimmunoassay technique. J Immunol. 1971; 106: 1166–1171.

    PubMed  CAS  Google Scholar 

  91. Robinson WS. DNA and DNA polymerase in the core of Dane particles. Am J Med Sci. 1975; 270: 151–159.

    PubMed  CAS  Google Scholar 

  92. Nielsen JO, Nielsen MH, Elling P. Differential distribution of Australia-antigen-associated particles in patients with liver disease and normal carriers. N Engl J Med. 1973; 288: 484–487.

    PubMed  CAS  Google Scholar 

  93. Mills CT, Lee E, Perrillo. Relationship between histology, aminotransferase levels, and viral replication in chronic hepatitis B. Gastroenterology. 1990; 99: 519–524.

    PubMed  CAS  Google Scholar 

  94. McDonald JA, Caruso L, Karayiannis P, et al. Diminished responsiveness of male chronic hepatitis B carriers with HTLV-III antibodies to recombinant alpha interferon. Hepatology. 1987; 7: 719–723.

    PubMed  CAS  Google Scholar 

  95. Perrillo RP, Regenstein FG, Roodman ST. Chronic hepatitis B in asymptomatic homosexual men with antibody to the human immunodeficiency virus. Ann Intern Med. 1986; 105: 382–383.

    PubMed  CAS  Google Scholar 

  96. Melbye M, Biggar RJ, Ebbesen P, et al. Long-term seropositivity for human T lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: Development of immunologic and clinical abnormalities. A longitudinal study. Ann Intern Med. 1986; 104: 496–500.

    PubMed  CAS  Google Scholar 

  97. Liaw YF, Tai DI, Chu CM, et al. The development of cirrhosis in patients with chronic type B hepatitis: A prospective study. Hepatology. 1988; 8: 493–496.

    PubMed  CAS  Google Scholar 

  98. Karrountzis GG, Redeker AG, Peters RL. Long term follow-up studies of patients surviving fulminant viral hepatitis. Gastroenterology. 1974; 67: 870–877.

    Google Scholar 

  99. Horney JT, Galambos JT. The liver during and after fulminant hepatitis. Gastroenterology. 1977; 73: 639–645.

    PubMed  CAS  Google Scholar 

  100. Ware AJ, Eigenbrodt EH, Combes B. Prognostic significance of subacute hepatic necrosis in acute hepatitis. Gastroenterology. 1975; 68: 519–524.

    PubMed  CAS  Google Scholar 

  101. Christie AB, Allam AA, Aref MK, El Muntasser IH, El-Nagel M. Pregnancy hepatitis in Libya. Lancet. 1976; 2: 827–829.

    PubMed  CAS  Google Scholar 

  102. Borhanmanesh F, Haghighi P, Hekmat K, Rezaizadeh K, Ghavami AG. Viral hepatitis during pregnancy: Severity and effect on gestation. Gastroenterology. 1973; 64: 304–312.

    PubMed  CAS  Google Scholar 

  103. Hieber JP, Dalton D, Shorey J, Combes B. Hepatitis and pregnancy. J Pediatr. 1977; 91: 545–549.

    PubMed  CAS  Google Scholar 

  104. Shalev E, Bassan HM. Viral hepatitis during pregnancy in Israel. Int J Gynaecol Obstet. 1982; 20: 73–78.

    PubMed  CAS  Google Scholar 

  105. Arakawa K, Tsuda F, Takahashi K, et al. Maternofetal transmission of IgG-bound hepatitis e antigen. Pediatr Res. 1982; 16: 247–250.

    PubMed  CAS  Google Scholar 

  106. Lin HH, Lee TY, Chen DS, et al. Transplacental leakage of HBeAg-positive maternal blood as the most likely route in causing intrauterine infection with hepatitis B virus. J Pediatr. 1987; 111: 877–881.

    PubMed  CAS  Google Scholar 

  107. Ohto H, Lin HH, Kawana T, Etoh T, Tohyama H. Intrauterine transmission of hepatitis B virus is closely related to placental leakage. J Med Virol. 1987; 21: 1–6.

    PubMed  CAS  Google Scholar 

  108. Schweitzer IL, Wing A, McPeak C, et al. Hepatitis and hepatitis-associated antigen in 56 mother-infant pairs. JAMA. 1972; 220: 1092–1095.

    PubMed  CAS  Google Scholar 

  109. Okada K, Yamada T, Miyakawa Y, et al. Hepatitis B surface antigen in the serum of infants after delivery from asymptomatic carrier mothers. J Pediatr. 1975; 87: 360–363.

    PubMed  CAS  Google Scholar 

  110. Gerety RJ, Schweitzer IL. Viral hepatitis type B during pregnancy, the neonatal period, and infancy. J Pediatr. 1977; 90: 368–374.

    PubMed  CAS  Google Scholar 

  111. Lee AKY, Ip HMH, Wong VCW. Mechanisms of maternal-fetal transmission of hepatitis B virus. J Infect Dis. 1978; 138: 668–671.

    PubMed  CAS  Google Scholar 

  112. Okada K, Kamiyama I, Inomata M, Imai M, Miyakawa Y, Mayumi M. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med. 1976; 294: 746–749.

    PubMed  CAS  Google Scholar 

  113. Beasley RP, Trepo C, Stevens CE, Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol. 1977; 105: 94–98.

    PubMed  CAS  Google Scholar 

  114. Stevens CE, Toy PT, Tong MJ, et al. Perinatal hepatitis B virus transmission in the United States: Prevention by passive-active immunization. JAMA. 1985; 253: 1740–1745.

    PubMed  CAS  Google Scholar 

  115. Biswas SC, Gupta I, Ganguly NK, Chawla Y, Dilawari JB. Prevalence of hepatitis B surface antigen in pregnant mothers and its perinatal transmission. Trans R Soc Trop Med Hyg. 1989; 83: 698–700.

    PubMed  CAS  Google Scholar 

  116. Dupuy JM, Frommel D, Alagille D. Severe viral hepatitis B in infancy. Lancet. 1975; 1: 191–194.

    PubMed  CAS  Google Scholar 

  117. Fawaz KA, Grady GF, Kaplan MM, et al. Repetitive maternal-fetal transmission of fetal hepatitis B. N Engl J Med. 1975;293:1357– 1359.

    PubMed  Google Scholar 

  118. Delaplane D, Yogev R, Crussi F, Shulman ST. Fatal hepatitis B in early infancy: The importance of identifying HBsAg-positive pregnant women and providing immunoprophylaxis to their newborns. Pediatrics. 1983; 72: 176–180.

    PubMed  CAS  Google Scholar 

  119. Chang MH, Chen DS, Hsu HC, Hsu HY, Lee CY. Maternal transmission of hepatitis B virus in childhood hepatocellular carcinoma. Cancer. 1989; 64: 2377–2380.

    PubMed  CAS  Google Scholar 

  120. Perrillo RP, Schiff ER, Davis GL, et al. A randomized controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med. 1990; 323: 295–301.

    PubMed  CAS  Google Scholar 

  121. Reesink HW, Reerink-Brongers EE, Lafeber-Schut BJT, Kalshoven-Benschop J, Brummelhuis HGJ. Prevention of chronic HBsAg carrier state in infants of HBsAg- positive mothers by hepatitis B immunoglobulin. Lancet. 1979; 1: 436–438.

    Google Scholar 

  122. Beasley RP, Hwang LY, Lin CC, et al. Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carreir state: Initial report of a randomized double-blind placebo-controlled trial. Lancet. 1981; 2: 388–393.

    PubMed  CAS  Google Scholar 

  123. Szmuness W, Stevens CE, Harley EJ, et al. Hepatitis B vaccine: Demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med. 1980; 303: 833–841.

    PubMed  CAS  Google Scholar 

  124. Scolnick EM, McLean AA, West DJ, McAleer WJ, Miller WJ, Buynak EB. Clinical evaluation in healthy adults of a hepatitis B vaccine made by recombinant DNA. JAMA. 1984; 251: 2812–2815.

    PubMed  CAS  Google Scholar 

  125. Gerety RJ, Tabor E. Newly licensed hepatitis B vaccine: Known safety and unknown risks. JAMA. 1983; 249: 745–746.

    PubMed  CAS  Google Scholar 

  126. Stevens CE. No increased incidence of AIDS in recipients of hepatitis B vaccine. N Engl J Med. 1983; 308: 1163–1164.

    Google Scholar 

  127. Phillips M, Cummins LM. Absence of sero-conversion following treatment with hepatitis B immune globulin containing antibody to human immunodeficiency virus. Hepatology. 1988; 8: 497–498.

    PubMed  CAS  Google Scholar 

  128. Tada H, Yanagida M, Mishina J, et al. Combined passive and active immunization for preventing perinatal transmission of hepatitis B virus carrier state. Pediatrics. 1982; 70: 613–619.

    PubMed  CAS  Google Scholar 

  129. Beasley RP, Hwang LY, Lee GC, et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet. 1983; 2: 1099–1102.

    PubMed  CAS  Google Scholar 

  130. Wong VCW, Ip HMH, Reesink HW, et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin: Double-blind randomized placebo-controlled study. Lancet. 1984;2:921–926.

    Google Scholar 

  131. Pongpipat D, Suvatte V, Assateerawatts A. Efficacy of hepatitis-B immunoglobulin and hepatitis-B vaccine in prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carrier of HBsAg and HBeAg. Asian Pac J Allergy Immunol. 1986; 4: 33–36.

    PubMed  CAS  Google Scholar 

  132. Xu ZY, Liu CB, Francis DP, et al. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: Preliminary report of a randomized, double-blind placebo-controlled and comparative trial. Pediatrics. 1985; 76: 713–718.

    PubMed  CAS  Google Scholar 

  133. Schaln SW, Mazel JA, deGast GC, et al. Prevention of hepatitis B infection in new-borns through mass screening and delayed vaccination of all infants of mothers with hepatitis B surface antigen. Pediatrics. 1989; 83: 1041–1048.

    Google Scholar 

  134. Poovorawan Y, Sanpavat S, Pongpunlert W, Chumdermpadetsuk S, Sentrakul P, Safary A. Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers. JAMA. 1989;269:3278–3281.

    Google Scholar 

  135. Chen DS, Hsu HM, Sung JL, et al. Immunization of newborns of HBsAg-positive mothers: A successful first step in control of hepatitis B virus in Taiwan. Hepatology. 1989;9:900–907.

    Google Scholar 

  136. London WT, O’Connell AP. Transplacental transmission of hepatitis B virus. Lancet. 1986; 1: 1037–1038.

    PubMed  CAS  Google Scholar 

  137. Tang SX, Yu GL. Intrauterine infection with hepatitis B virus. Lancet. 1990; 335: 302.

    PubMed  CAS  Google Scholar 

  138. Li L, Shen MH, Li YQ, et al. A study of mother-infant transmission of hepatitis B virus. Presented at International Symposium on Liver Cancer and Hepatitis; Shanghai; 1986.

    Google Scholar 

  139. Centers for Disease Control. Recommendations of the Immunization Practices Advisory Committee. Prevention of perinatal transmission of hepatitis B virus: Prenatal screening of all pregnant women for hepatitis B surface antigen. Morb Mortal Wkly Rep. 1988; 37: 341–346.

    Google Scholar 

  140. American Academy of Pediatrics: Committee on Infectious Diseases. Universal hepatitis B immunization. Pediatrics. 1992; 89: 795–800.

    Google Scholar 

  141. Desmyter J, Bradbourne AF, Vermylen C, Daniels R, Boelaert J. Hepatitis B immunoglobulin in prevention of HBsAg antigenaemia in haemodialysis patients. Lancet. 1975; 2: 377–379.

    Google Scholar 

  142. Iwarson S, Ahlmen J, Erickson E, et al. Hepatitis B immune serum globulin and standard gamma globulin in prevention of hepatitis B infection among hospital staff: A preliminary report. Am J Med Sci. 1975;270:385– 389.

    PubMed  Google Scholar 

  143. Grady GF. Viral hepatitis passive prophylaxis with globulins: State of the art in 1978. In: V yas GN, Cohen SN, Schmidt R, eds. Viral Hepatitis: A Contemporary Assessment of Etiology, Epidemiology, Pathogenesis, and PreventionPhiladelphia: Franklin Institute Press; 1978: 467–476.

    Google Scholar 

  144. Szmuness W, Stevens CE, Zange A, et al. A controlled clinical trial on the efficacy of the hepatitis B vaccine (Heptavax B): A final report. Hepatology. 1981; 1: 377–385.

    PubMed  CAS  Google Scholar 

  145. Dienstag JL, et al. Hepatitis B vaccine in health-care personnel: A randomized, doubleblind, placebo-controlled trial. Hepatology. 1982; 2: 696.

    Google Scholar 

  146. Francis DP, Hadler SC, Thompson SE, et al. The prevention of hepatitis B with vaccine: Report of the Centers for Disease Control multi-center trial among homosexual men. Ann Intern Med. 1982; 97: 362–366.

    PubMed  CAS  Google Scholar 

  147. Deinhardt F . Aspects of vaccination against hepatitis B: Passive-active immunization schedules and immune responses in different age groups. Scand J Infect Dis. 1983;suppl 38:17–23.

    CAS  Google Scholar 

  148. Szmuness W, Stevens CE, Oleszko WR, Goodman A. Passive-active immunization against hepatitis B: Immunogenicity studies in adult Americans. Lancet. 1981; 1: 575–577.

    PubMed  CAS  Google Scholar 

  149. Jilg W, Schmidt M, Deinhardt F, et al. Hepatitis B vaccination: How long does protection last? Lancet. 1984; 2: 458.

    PubMed  CAS  Google Scholar 

  150. Immunization Practices Advisory Committee. Postexposure prophylaxis of hepatitis B. Morb Mortal Wkly Rep. 1984; 33: 285–290.

    Google Scholar 

  151. Malecki JM, Guarin O, Hulbert A, Brum- back CL. Prevalence of hepatitis B surface antigen among women receiving prenatal care at the Palm Beach County Health Department. Am J Obstet Gynecol. 1986; 154: 625–626.

    PubMed  CAS  Google Scholar 

  152. Kumar ML, Dawson NV, McCullough AJ, et al. Should all pregnant women be screened for hepatitis B. Ann Intern Med. 1987; 107: 273–277.

    PubMed  CAS  Google Scholar 

  153. Jonas MM, Schiff ER, O’Sullivan MJ, et al. Failure of Centers for Disease Control criteria to identify hepatitis B infection in a large municipal obstetrical population. Ann Intern Med. 1987; 107: 335–337.

    PubMed  CAS  Google Scholar 

  154. Summers PR, Biswas MK, Pastorek JG II, Pernoll ML, Smith LG, Bean BE. The pregnant hepatitis B carrier: Evidence favoring comprehensive antepartum screening. Obstet Gynecol 1987; 156: 166–169.

    Google Scholar 

  155. Wetzel AM, Kirz DS. Routine hepatitis screening in adolescent pregnancies: Is it cost effective? AM J Obstet Gynecol. 1987; 156: 166–169.

    PubMed  CAS  Google Scholar 

  156. Butterfield CR, Shockley M, SanMiguel G, Rosa C. Routine screening for hepatitis B in an obstetric population. Obstet Gynecol. 1990; 76: 25–27.

    PubMed  CAS  Google Scholar 

  157. Dinsmoor MJ, Gibbs RS. Prevalence of asymptomatic hepatitis B infection in pregnant Mexican-American women. Obstet Gynecol. 1990; 76: 239–240.

    PubMed  CAS  Google Scholar 

  158. Kane MA, Hadler SC, Margolis HS, Maynard JE. Routine prenatal screening for hepatitis B surface antigen. JAMA. 1988; 259: 408–409.

    PubMed  CAS  Google Scholar 

  159. ACOG Committee Opinion. Guidelines for hepatitis B virus screening and vaccination during pregnancy. American College of Obstetricians and Gynecologists; January 1990: 78.

    Google Scholar 

  160. Arevalo JA, Washington AE. Cost-effectiveness of prenatal screening and immunization for hepatitis B virus. JAMA. 1988; 259: 365–369.

    PubMed  CAS  Google Scholar 

  161. Maynard JE, Kane MA, Hadler SC. Global control of hepatitis B through vaccination: Role of hepatitis B vaccine in the expanded programme on immunization. Rev Infect Dis. 1989; 11 (S3): S574–S578.

    PubMed  Google Scholar 

  162. Toukan A. Strategy for the control of hepatitis B virus infection in the Middle East and North Africa: The Middle East Regional Study Group. Vaccine. 1990; S8: S117–S121.

    Google Scholar 

  163. Kane MA, Hadler SC, Margolis HS. Prenatal screening for hepatitis B antigen-Reply. JAMA. 1989; 261: 1727–1728.

    Google Scholar 

  164. Beasley RP, Stevens CE. Vertical transmission of HBV and interruption with globulin. In: Vyas GM, Cohen SN, Schmid T, eds. Viral Hepatitis: A Contemporary Assessment of Etiology, Epidemiology, Pathogenesis and Prevention. Philadelphia: Franklin Institute Press; 1978: 333–345.

    Google Scholar 

  165. Silverman NS, Darby MJ, Ronkin SL, Wapner RJ. Hepatitis B prevalence in an unregistered prenatal population. JAMA. 1991; 266: 282–285.

    Google Scholar 

  166. Rizzetto M, Canese MG, Arico S, et al. Immunofluorescence detection of new antigen-antibody system (δ/ anti- δ) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut. 1977; 18: 997–1003.

    PubMed  CAS  Google Scholar 

  167. Gerken G, Meyer zum Buschenfelde K-H. Chronic hepatitis delta (HDV) infection. Hepatogastroenterology. 1991; 38: 29–32.

    PubMed  CAS  Google Scholar 

  168. Makino S, Chang MF, Shieh CK, et al. Molecular cloning and sequencing of a human hepatitis delta virus RNA. Nature. 1987; 329: 343–346.

    PubMed  CAS  Google Scholar 

  169. Kos A, Dijkema R, Arnberg C, et al. The hepatitis delta virus possesses a circular RNA. Nature. 1986; 323: 558–560.

    PubMed  CAS  Google Scholar 

  170. Wang KS, Choo QL, Weiner AJ, et al. Structure, sequence and expression of the hepatitis delta viral genome. Nature. 1986;323:508–513.

    PubMed  CAS  Google Scholar 

  171. Ponzetto A, Hoofnagle JH, Seeff LB. Anti-body to the hepatitis B virus-associated delta-agent in immune serum globulins. Gastroenterology. 1984; 87: 1213–1216.

    CAS  Google Scholar 

  172. Rizzetto M. The delta agent. Hepatology. 1983; 3: 729–737.

    PubMed  CAS  Google Scholar 

  173. Hoofnagle JH. Type D (delta) hepatitis. JAMA. 1989; 261: 1321–1325.

    PubMed  CAS  Google Scholar 

  174. Jacobson IM, Dienstag JL, Werner BG, et al. Epidemiology and clinical impact of hepatitis D virus (delta) infection. Hepatology. 1985; 5: 188–191.

    PubMed  CAS  Google Scholar 

  175. Smedile A, Farci P, Verme G, et al. Influence of delta infection on severity of hepatitis B. Lancet. 1982; 2: 945–947.

    PubMed  CAS  Google Scholar 

  176. Govindarajan S, Chin KP, Redeker AG, et al. Fulminant B viral hepatitis: Role of delta agent. Gastroenterology. 1984; 86: 1717–1720.

    Google Scholar 

  177. Rizzetto M, Verme G, Recchia S, et al. Chronic HBsAg hepatitis with intrahepatic expression of delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med. 1983; 98: 437–441.

    PubMed  CAS  Google Scholar 

  178. Colombo M, Canbieri R, Rumi MG, et al. Long-term delta superinfection in hepatitis B surface antigen carriers and its relationship to the course of chronic hepatitis. Gastroenterology. 1983; 85: 235–239.

    PubMed  CAS  Google Scholar 

  179. Moestrup T, Hansonn BG, Widell A, et al. Clinical aspects of delta infection. Br Med J. 1983; 286: 87–90.

    CAS  Google Scholar 

  180. Shattock AG, Irwin FM, Morgan BM, et al. Increased severity and morbidity of acute hepatitis in drug abusers with simultaneously acquired hepatitis B and D virus infections. Br Med J. 1985; 290: 1377–1380.

    CAS  Google Scholar 

  181. Novick DM, Farci P, Croxson TS, et al. Hepatitis D virus and human immunodeficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive. J Infect Dis. 1988; 158: 795–803.

    PubMed  CAS  Google Scholar 

  182. Housset C, Pol S, Carnot F, et al. Interactions between human immunodeficiency virus-1, hepatitis delta virus and hepatitis B virus infection in 260 chronic carriers of hepatitis B virus. Hepatology. 1992; 15: 578–583.

    PubMed  CAS  Google Scholar 

  183. Zanetti RA, Gerroni P, Magliano EM, et al. Perinatal transmission of the hepatitis B virus and of the HBV-associated delta agent from mothers to offspring in Northern Italy. J Med Virol. 1982;9:139–148.

    PubMed  CAS  Google Scholar 

  184. Zignegno AL, Samuel D, Gentillini P, et al. Hepatitis D virus (HDV) RNA in patients with acute delta hepatitis and in liver graft recipients. J Hepatol. 1989; 9 (S–2): 98.

    Google Scholar 

  185. Non-A, non-B? (editorial). Lancet. 1975;2:64– 65.

    Google Scholar 

  186. Alter HJ. New kit on the block: Evaluation of second-generation assays for detection of antibody to the hepatitis C virus. Hepatology. 1992; 15: 350–353.

    PubMed  CAS  Google Scholar 

  187. Esteban JI, Esteban R, Viladomiu L, et al. Hepatitis C virus antibodies among high risk groups in Spain. Lancet. 1989; 2: 294–297.

    PubMed  CAS  Google Scholar 

  188. Stevens CE, Taylor PE, Pindyck J, et al. Epidemiology of hepatitis C virus: A preliminary study in volunteer blood donors. JAMA. 1990; 263: 49–53.

    PubMed  CAS  Google Scholar 

  189. Van Doornum GJJ, Hooykas C, Cuypers MT, et al. Prevalence of hepatitis C virus infections among heterosexuals with multiple partners. J Med Virol 1991; 35: 22–27.

    PubMed  Google Scholar 

  190. Fairley CK, Leslie DE, Nicholson S, et al. Epidemiology of hepatitis C virus in Victoria. Med J Aust. 1990; 153: 274–276.

    Google Scholar 

  191. Yenen OS, Badur S. Prevalence of antibodies to hepatitis C virus in blood donors and risk groups in Istanbul, Turkey. Eur J Clin Microbiol Infect Dis. 1991; 23: 19–24.

    Google Scholar 

  192. Sanchez-Quijano A, Rey C, Aguado I, et al. Hepatitis C virus infection in sexually promiscuous groups. Eur J Clin Microbiol Infect Dis. 1990; 9: 610–612.

    PubMed  CAS  Google Scholar 

  193. Widell A, Hansson BG, Berntorp E, et al. Antibody to a hepatitis C virus related protein among patients at high risk for hepatitis B. Scand J Infect Dis. 1991; 10: 19–24.

    Google Scholar 

  194. Brettler DB, Alter HJ, Dienstag JL, et al. Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients. Blood. 1990; 76: 254–256.

    PubMed  CAS  Google Scholar 

  195. Bell J, Batey RG, Farrell AC, et al. Hepatitis C virus in intravenous drug users. Med J Aust. 1990; 153: 274–276.

    PubMed  CAS  Google Scholar 

  196. Van den Hoek JAR, van Haastrecht HJA, Goudsmit J, et al. Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam. J Infect Dis. 1990; 162: 823–826.

    PubMed  Google Scholar 

  197. Alter MJ, Sampliner RE. Hepatitis C: And miles to go before we sleep. N. Engl. J. Med. 1989; 321: 1538–1540.

    PubMed  CAS  Google Scholar 

  198. Esteban JI, Gonzalez A, Hernandez JM, et al. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med. 1990; 323: 1107–1112.

    PubMed  CAS  Google Scholar 

  199. Japanese Red Cross Non-A, Non-B Hepatitis Research Group. Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis. Lancet. 1991; 338: 1040–1041.

    Google Scholar 

  200. Donahue JG, Munoz A, Ness PM, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med. 1992; 327: 369–373.

    PubMed  CAS  Google Scholar 

  201. Sugitani M, Inchauspe H, Shindo M, et al. Sensitivity of serologic assays to identify blood donors with hepatitis C viremia. Lancet. 1992; 339: 1018–1019.

    PubMed  CAS  Google Scholar 

  202. Donahue JG, Nelson KE, Munoz A, et al. Transmission of HIV by transfusion of screened blood. N Engl J Med. 1990; 323: 1709.

    PubMed  CAS  Google Scholar 

  203. Busch MP, Eble BE, Khayam-BashiH, et al. Evaluation of screened blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells. N Engl. J. Med. 1991;235:1–5.

    Google Scholar 

  204. Nelson KE, Donahue JG, Munoz A, et al. Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery. A multicenter study of HIV-I and HTLV-I/II infections. Ann Int Med. 1992; 117: 554–559.

    PubMed  CAS  Google Scholar 

  205. Alter MJ, Coleman PJ, Alexander WJ, et al. Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA. 1989; 262: 1201–1205.

    PubMed  CAS  Google Scholar 

  206. Lin HH, Hsu HY, Chang MH, et al. Low prevalence of hepatitis C virus and infrequent perinatal or spouse infections in pregnant women in Taiwan. J Med Virol. 1991; 35: 237–240.

    PubMed  Google Scholar 

  207. Tor J, Llibre JM, Carbonell M, et al. Sexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIV. BMJ. 1990; 301: 1130–1133.

    PubMed  CAS  Google Scholar 

  208. Eyster ME, Alter HJ, Aledort LM, et al. Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann Intern Med. 1991;115:764–768.

    PubMed  CAS  Google Scholar 

  209. Brown J, Dourakis S, Karayiannis P, et al. Seroprevalence of hepatitis C virus nueleocapsid antibodies in patients with crypto-genic chronic liver disease. Hepatology. 1992; 15: 175–179.

    PubMed  CAS  Google Scholar 

  210. Okamoto H, Tsuda F, Machida a, et al. Antibodies against synthetic oligopeptided deduced from the putative core gene for the diagnosis of hepatitis C virus infection. Hepatology. 1992; 15: 180–186.

    PubMed  CAS  Google Scholar 

  211. Liddle C, Crewe EB, Swanson NR, et al. Does hepatitis C virus play a role in “non-viral” chronic liver disease? Med J Aust. 1990; 153: 265–271.

    PubMed  CAS  Google Scholar 

  212. Jeffers LJ, Hasan F, deMedina M, et al. Prevalence of antibodies to hepatitis C virus among patients with cryptogenic chronic hepatitis and cirrhosis. Hepatology. 1992; 15: 187–190.

    PubMed  CAS  Google Scholar 

  213. Kiyosawa K, Sodeyama T, Tanaka, et al. Inter-relationship of blood transfusion, non- A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology. 1990; 12: 671–675.

    PubMed  CAS  Google Scholar 

  214. Sbolli G, Zanetti AR, Tanzi E, et al. Serum antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. J Med Virol. 1990; 30: 230–232.

    PubMed  CAS  Google Scholar 

  215. Kew MC, Houghton M, Choo QL, et al. Hepatitis C virus in southern African blacks with hepatocellular carcinoma. Lancet. 1990; 335: 873–874.

    PubMed  CAS  Google Scholar 

  216. Bruix J, Barrera JM, Calvet X, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet. 1989; 2: 1004–1006.

    PubMed  CAS  Google Scholar 

  217. Martin P. Hepatitis C. More than just a liver disease. Gastroenterology. 1993; 104: 320–323.

    PubMed  CAS  Google Scholar 

  218. Jori GP, Buonanno G, D’Orofrio F, et al. Incidence and immunochemical features of serum cryoglobulin in chronic liver disease. Gut. 1977; 18: 245–249.

    PubMed  CAS  Google Scholar 

  219. Popp JW, Dienstag JL, Wands JR, et al. Essential mixed cryoglobulinemia without evidence for hepatitis B virus infections. Ann Intern Med. 1980; 92: 379–383.

    PubMed  Google Scholar 

  220. Ferri C, Greco F, Longombardo G, et al. Antibodies to hepatitis C in patients with mixed cryoglobulinemia. Arthritis Rheum. 1991; 34: 1606–1610.

    PubMed  CAS  Google Scholar 

  221. Ferri C, Greco F, Longombardo G, et al. Association between hepatitis C virus and mixed cryoglobulinemia. Clin Exp Rheumatol. 1991; 9: 621–624.

    PubMed  CAS  Google Scholar 

  222. Marcellin P, Descamps V, Martinot-Peignoux M, et al. Cryoglobulinemia with vasculitis associated with hepatitis C infection. Gastroenterology. 1992; 103: 272–277.

    Google Scholar 

  223. Coll O, Torne A, Martinez JM, et al. HCV vertical transmission. Preliminary data of a prospective study. Abstract #32, Infectious Diseases Society for Obstetrics and Gynecology Annual Meeting; August, 1991.

    Google Scholar 

  224. Reinus JF, Leikin EL, Alter HJ, et al. Failure to detect vertical transmission of hepatitis C virus. Ann Intern Med. 1992; 117: 881–886.

    PubMed  CAS  Google Scholar 

  225. Bohman VR, Stettier W, Little BB, et al. Seroprevalence and risk factors for hepatitis C virus antibody in pregnant women. Obstet Gynecol 1992; 80: 609–613.

    PubMed  CAS  Google Scholar 

  226. Silverman NS, Jenkin BK, Wu C, et al. Hepatitis C virus in pregnancy: Seroprevalence and risk factors for infection. Am J Obstet Gynecol. 1993; 169: 583–587.

    PubMed  CAS  Google Scholar 

  227. Wejstal R, Norkrans G. Chronic non-A, non-B hepatitis in pregnancy: Outcome and possible transmission to the offspring. Scand J Infect Dis. 1989; 21: 485–490.

    PubMed  CAS  Google Scholar 

  228. Wejstal R, Hermodsson S, Iwarson S, et al. Mother to infant transmission of hepatitis C virus infection. J Med Virol. 1990; 30: 178–180.

    PubMed  CAS  Google Scholar 

  229. Wejstal R, Widell A, Mansson AS, et al. Mother-to-infant transmission of hepatitis C virus. Ann Intern Med. 1992; 117: 887–890.

    PubMed  CAS  Google Scholar 

  230. Giovannini M, Tagger A, Ribero ML, et al. Maternal-infant transmission of hepatitis C virus and HIV infections: a possible interaction. Lancet 1990; 335: 1216–1217.

    Google Scholar 

  231. Thaler MM, Park CK, Landers DV, et al. Vertical transmission of hepatitis C virus. Lancet 1991; 338: 17–18.

    PubMed  CAS  Google Scholar 

  232. Novati R, Thiers V, Monforte AD, et al. Mother-to-child transmission of hepatitis C virus detected by nested polymerase chain reaction. J Infect Dis. 1992; 165: 720–723.

    PubMed  CAS  Google Scholar 

  233. Hsu HH, Wright TL, Luba D, et al. Failure to detect hepatitis C virus genome in human secretions with the polymerase chain reaction. Hepatology. 1991; 14: 763–767.

    PubMed  CAS  Google Scholar 

  234. Wang JT, Want TH, Sheu JC, et al. Hepatitis C virus RNA in saliva of patients with post-transfusion hepatitis and low effieciency of transmission among spouses. J Med Virol. 1992; 36: 28–31.

    PubMed  CAS  Google Scholar 

  235. Kuroki T, Nishiguchi S, Fukuda K, et al. Mother-to-child transmission of hepatitis C virus. J Infect Dis. 1991; 164: 427–428.

    PubMed  CAS  Google Scholar 

  236. Brillanti S, Masci C, Ricci P, et al. Significance of IgM antibody to hepatitis C virus in patients with chronic hepatitis C. Hepatology. 1992; 15: 998–1001.

    PubMed  CAS  Google Scholar 

  237. Choo QL, Kuo g, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B hepatitis genome. Science. 1989; 244: 359–362.

    PubMed  CAS  Google Scholar 

  238. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989; 244: 362–364.

    PubMed  CAS  Google Scholar 

  239. Chaudhary RK, MacLean C. Evaluation of first-and second-generation RIBA kits for detection of antibody to hepatitis C virus. J Clin Microbiol. 1991; 29: 2329–2330.

    PubMed  CAS  Google Scholar 

  240. McHutchinson JG, Person JL, Govindarajan S, et al. Improved detection of hepatitis C virus antibodies in high-risk populations. Hepatology. 1992; 15: 19–25.

    Google Scholar 

  241. Vallari DS, Jett BW, Alter HJ, et al. Serological markers of posttransfusion hepatitis C viral infection. J Clin Microbiol. 1992; 30: 552–556.

    PubMed  CAS  Google Scholar 

  242. Alter HJ, Jett BW, Polito AJ, et al. Analysis of the role of HCV in transfusion-associated hepatitis. In: Hollinger FB, Lemon SM, Gust I, eds. Viral hepatitis and liver disease. Baltimore: Williams & Wilkins, 1991: 396–402.

    Google Scholar 

  243. Wang JT, Wang TH, Lin JT, et al. Improved serodiagnopsis of posttransfusion hepatitis C virus infection by a second-generation immunoassay based on multiple recombinant antigens. Vox Sang. 1992; 62: 21–24.

    PubMed  CAS  Google Scholar 

  244. Inchauspe G, Abe K, Zebedee S, et al. Use of conserved sequences from hepatitis C virus for the detection of viral RNA in infected sera by polymerase chain reaction. Hepatology. 1991; 14: 595–600.

    PubMed  CAS  Google Scholar 

  245. Wang JT, Wang TH, Sheu JC, et al. Effects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virus. J Clin Microbiol. 1992; 30: 750–753.

    PubMed  CAS  Google Scholar 

  246. Cha TA, Beall E, Irvine B, et al. At least five related, but distinct, hepatitis C viral genotypes exist. Proc Natl Acad Sci USA. 1992; 89: 7144–7148.

    PubMed  CAS  Google Scholar 

  247. Bukh J, Purcell RH, Miller RH. Sequence analysis of the 5’ noncoding region of hepatitis C virus. Proc Natl Acad Sci USA. 1992; 89: 4942–4946.

    PubMed  CAS  Google Scholar 

  248. Lee CH, Cheng C, Wang J, et al. Identification of hepatitis C viruses with a noncom-served sequence of the 5’ untranslated region. J Clin Microbiol. 1992; 30: 1602–1604.

    PubMed  CAS  Google Scholar 

  249. Sanchez-Quijano A, Pineda JA, Lissen E, et al. Prevention of post-transfusion non-A, non-B hepatitis by nonspecific immunoglobulin in heart surgery patients. Lancet. 1988; 1: 1245–1249.

    PubMed  CAS  Google Scholar 

  250. Snydman DR. Hepatitis in pregnancy. N Engl J Med. 1985; 313: 1398–1401.

    PubMed  CAS  Google Scholar 

  251. Seeff LB, Hoofnagle JH. Immunoprophylaxis of viral hepatitis. Gastroenterology. 1979; 77: 161–182.

    PubMed  CAS  Google Scholar 

  252. Davis GL, Baiart LA, Schiff ER, et al. Treatment of chronic hepatitis C with recombinant interferon alfa: A multicenter randomized, controlled trial. N Engl J Med. 1989; 321: 1501–1506.

    PubMed  CAS  Google Scholar 

  253. DiBisceglie AM, Martin P, Kassianides c, et al. Recombinant interferon alfa therapy for chronic hepatitis C: A randomized double-blind, placebo-controlled trial. N Engl J Med. 1989; 321: 1506–1510.

    CAS  Google Scholar 

  254. Balayan MS, Anjaparidze AG, Savinskaya SS, et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecaloral route. Intervirology. 1983; 20: 23–31.

    PubMed  CAS  Google Scholar 

  255. Bradley DW, Krawczynski K, Cook EH, Jr., et al. Enterically transmitted non-A, non-B hepatitis: Serial passage of disease in cynomolgus macaques and tamarins and recovery of disease–associated 27-to 34-nm viruslike particles. Proc Natl Acad Sci USA. 1987; 84: 6277.

    PubMed  CAS  Google Scholar 

  256. Reyes GR, Purdy MA, Kim JP, et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science. 1990; 247: 1335–1339.

    PubMed  CAS  Google Scholar 

  257. Favorov MO, Fields HA, Purdy MA, et al. Serologic identification of hepatitis E virus infections in epidemic and endemic settings. J Med Virol. 1992; 36: 246–250.

    CAS  Google Scholar 

  258. Bradley DW. Hepatitis E: epidemiology, aetiology, and molecular biology. Rev Med Virol. 1992; 2: 19–28.

    Google Scholar 

  259. Smego RA, Khaliq AA. Epidemic non-A, non-B hepatitis in urban Karachi, Pakistan. Am J Trop Hyg. 1988; 38: 628–632.

    Google Scholar 

  260. DeCock KM, Bradley DW, Sandford NL, et al. Epidemic non-A, non-B hepatitis in patients from Pakistan. Ann Int Med. 1987: 106: 227–230.

    CAS  Google Scholar 

  261. Myint H, Soe MM, Khin T, et al. A clinical and epidemiological study of an epidemic of non-A, non-B hepatitis in Rangoon. Am J Trop Med Hyg. 1985; 34: 1183–1189.

    Google Scholar 

  262. Gust ID, Purcell RH. Report of a workshop: Non-A, non-B hepatitis. J Infect Dis. 1987; 156: 630–635.

    PubMed  CAS  Google Scholar 

  263. Bader T, Krawczynski K, Polish L, et al. Hepatitis E in a U.S. traveler to Mexico. N Engl J Med. 1991; 325: 1659.

    PubMed  CAS  Google Scholar 

  264. Velazquez O, Stetler HC, Avila C, et al. Epidemic transmission of enterically transmitted non-A, non-B hepatitis in Mexico, 1986–1987. JAMA. 1990; 263: 3281–3285.

    PubMed  CAS  Google Scholar 

  265. Centers for Disease Control and Prevention. Hepatitis E among U.S. travelers, 1989–1992. Morb Mortal Wkly Rep. 1993; 42: 1–4.

    Google Scholar 

  266. Tsega E, Hansson BG, Krawczynski K, et al. Acute sporadic viral hepatitis in Ethiopia: Causes, risk factors, and effects on pregnancy. Clin Infect Dis. 1992; 14: 961–965.

    PubMed  CAS  Google Scholar 

  267. Viswanathan R . Epidemiology. Indian J Med Res. 1987;l(Suppl l):l–29.

    Google Scholar 

  268. Khuroo MS, Saleem M, Teli MR, et al. Failure to detect chronic liver disease after epidemic non-A, non-B hepatitis. Lancet. 1980; 2: 97–98.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Neil S. Silverman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynecology, Wayne State University School of Medicine, 6071 West Outer Drive, 48235, Detroit, MI, USA

    Bernard Gonik M.D. (Professor and Vice Chairman Chief of Obstetrics and Gynecology—Grace Hospital) (Professor and Vice Chairman Chief of Obstetrics and Gynecology—Grace Hospital)

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Silverman, N.S. (1994). Hepatitis Viruses. In: Gonik, B. (eds) Viral Diseases in Pregnancy. Clinical Perspectives in Obstetrics and Gynecology. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2640-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-2640-6_9

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7620-3

  • Online ISBN: 978-1-4612-2640-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation